NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
TSX-V:NLH - CA66980G1090 - Common Stock
0.3 CAD
-0.03 (-7.69%)
Taking everything into account, NLH scores 4 out of 10 in our fundamental rating. NLH was compared to 15 industry peers in the Health Care Providers & Services industry. NLH has only an average score on both its financial health and profitability. NLH does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year NLH has reported negative net income.
NLH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
Each year in the past 5 years NLH had a positive operating cash flow.
1.2 Ratios
The Return On Assets of NLH (0.49%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 0.62%, NLH is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Return On Invested Capital of NLH (3.34%) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.49% | ||
| ROE | 0.62% | ||
| ROIC | 3.34% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of NLH (0.41%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of NLH has declined.
NLH has a Operating Margin (3.04%) which is comparable to the rest of the industry.
With a Gross Margin value of 39.13%, NLH perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
In the last couple of years the Gross Margin of NLH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.04% | ||
| PM (TTM) | 0.41% | ||
| GM | 39.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NLH is destroying value.
NLH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NLH has more shares outstanding
NLH has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.50 indicates that NLH is not in any danger for bankruptcy at the moment.
NLH has a better Altman-Z score (3.50) than 86.67% of its industry peers.
The Debt to FCF ratio of NLH is 2.32, which is a good value as it means it would take NLH, 2.32 years of fcf income to pay off all of its debts.
NLH has a Debt to FCF ratio of 2.32. This is amongst the best in the industry. NLH outperforms 86.67% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that NLH is not too dependend on debt financing.
The Debt to Equity ratio of NLH (0.04) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 2.32 | ||
| Altman-Z | 3.5 |
ROIC/WACC0.42
WACC7.91%
2.3 Liquidity
A Current Ratio of 0.82 indicates that NLH may have some problems paying its short term obligations.
The Current ratio of NLH (0.82) is comparable to the rest of the industry.
A Quick Ratio of 0.82 indicates that NLH may have some problems paying its short term obligations.
NLH has a Quick ratio of 0.82. This is comparable to the rest of the industry: NLH outperforms 53.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.38% over the past year.
The earnings per share for NLH have been decreasing by -11.19% on average. This is quite bad
NLH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.63%.
NLH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.16% yearly.
EPS 1Y (TTM)15.38%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-311.54%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%26.55%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NLH indicates a somewhat cheap valuation: NLH is cheaper than 73.33% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NLH indicates a somewhat cheap valuation: NLH is cheaper than 73.33% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.47 | ||
| EV/EBITDA | 13.41 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NLH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:NLH (9/2/2025, 7:00:00 PM)
0.3
-0.03 (-7.69%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap26.19M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.68 | ||
| P/FCF | 13.47 | ||
| P/OCF | 13.23 | ||
| P/B | 1.02 | ||
| P/tB | 23.48 | ||
| EV/EBITDA | 13.41 |
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY7.43%
OCF(TTM)0.02
OCFY7.56%
SpS0.44
BVpS0.29
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.49% | ||
| ROE | 0.62% | ||
| ROCE | 4.39% | ||
| ROIC | 3.34% | ||
| ROICexc | 3.59% | ||
| ROICexgc | 267.42% | ||
| OM | 3.04% | ||
| PM (TTM) | 0.41% | ||
| GM | 39.13% | ||
| FCFM | 5.02% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score5
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 2.32 | ||
| Debt/EBITDA | 0.53 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 5.13 | ||
| Cash Conversion | 92.26% | ||
| Profit Quality | 1214.21% | ||
| Current Ratio | 0.82 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 3.5 |
F-Score5
WACC7.91%
ROIC/WACC0.42
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.38%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%-311.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%26.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-37.27%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y-37.45%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%